SSRIs for vasodepressor syncope?

Postgraduate Medicine

Volumn 108, Issue 6, 2000, Pages

  Grubb, B P ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; METHYSERGIDE; ONDANSETRON; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANOREXIA; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOTENSION; INSOMNIA; NOTE; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RECURRENT DISEASE; SYMPATHETIC BLOCKING; SYNCOPE;

EID: 0033742306     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.11.1301     Document Type: Note

References (5)

1. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances
2. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope
3. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents
4. The role of serotonin re-uptake inhibitors in preventing recurrent unexplained childhood syncope: A preliminary report
5. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study